TANG CAPITAL PARTNERS LP 13D and 13G filings for Corvus Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-02-14 4:00 pm Sale | 2022-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL PARTNERS LP | 0 0.000% | -3,101,709 (Position Closed) | Filing |
| 2022-02-14 4:00 pm Purchase | 2021-12-31 | 13G | Corvus Pharmaceuticals, Inc. CRVS | TANG CAPITAL PARTNERS LP | 3,101,709 6.700% | 3,101,709 (New Position) | Filing |